DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+18.6%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.69B
AUM Growth
+$6.69B
(+11%)
Cap. Flow
-$45.5M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
681
New
246
Increased
84
Reduced
73
Closed
235
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$72.1M |
| 2 |
Indivior
INDV
|
$49.7M |
| 3 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$45.7M |
| 4 |
Merus
MRUS
|
$32.9M |
| 5 |
Viatris
VTRS
|
$30.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$102M |
| 2 |
Surgery Partners
SGRY
|
$94.4M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
$57.6M |
| 4 |
BioNTech
BNTX
|
$49.8M |
| 5 |
Integra LifeSciences
IART
|
$42.8M |
Sector Composition
| 1 | Healthcare | 87.45% |
| 2 | Industrials | 0.72% |
| 3 | Technology | 0.55% |
| 4 | Financials | 0.42% |
| 5 | Consumer Discretionary | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Collegium Pharmaceutical
COLL
$1.25B
| $1.22M | 0.02% |
31,696
+18,400
| +138% | +$711K |
|
102
3M
MMM
$81B
| $1.21M | 0.02% |
+8,875
| New | +$1.21M |
|
103
Lear
LEA
$5.77B
| $1.21M | 0.02% |
11,067
+5,510
| +99% | +$601K |
|
104
Diamond Hill
DHIL
$387M
| $1.2M | 0.02% |
+7,404
| New | +$1.2M |
|
105
Novavax
NVAX
$1.2B
| $1.17M | 0.02% |
+92,597
| New | +$1.17M |
|
106
Life Time Group Holdings
LTH
$6.11B
| $1.16M | 0.02% |
47,343
+14,411
| +44% | +$352K |
|
107
Mativ Holdings
MATV
$666M
| $1.16M | 0.02% |
68,020
+49,143
| +260% | +$835K |
|
108
ArcBest
ARCB
$1.65B
| $1.15M | 0.02% |
+10,614
| New | +$1.15M |
|
109
MannKind Corp
MNKD
$1.69B
| $1.15M | 0.02% |
182,776
-13,801
| -7% | -$86.8K |
|
110
Amplitude
AMPL
$1.48B
| $1.14M | 0.02% |
+127,474
| New | +$1.14M |
|
111
Boston Beer
SAM
$2.38B
| $1.12M | 0.02% |
+3,876
| New | +$1.12M |
|
112
Acadia Healthcare
ACHC
$2.15B
| $1.12M | 0.02% |
+17,673
| New | +$1.12M |
|
113
Dynatrace
DT
$15.1B
| $1.11M | 0.02% |
+20,722
| New | +$1.11M |
|
|
HTO
114
H2O America Common Stock
HTO
$1.75B
| $1.1M | 0.02% |
+19,014
| New | +$1.1M |
|
115
The Oncology Institute
TOI
$302M
| $1.1M | 0.02% |
3,360,052
| – | – |
|
116
Trane Technologies
TT
$90.9B
| $1.09M | 0.02% |
+2,799
| New | +$1.09M |
|
117
Hallador Energy
HNRG
$703M
| $1.06M | 0.02% |
112,711
+71,819
| +176% | +$677K |
|
118
Twist Bioscience
TWST
$1.57B
| $1.06M | 0.02% |
23,424
+3,968
| +20% | +$179K |
|
119
Consolidated Edison
ED
$35.3B
| $1.05M | 0.02% |
+10,098
| New | +$1.05M |
|
120
Johnson Controls International
JCI
$68.9B
| $1.05M | 0.02% |
+13,530
| New | +$1.05M |
|
121
Steelcase
SCS
$1.93B
| $1.05M | 0.02% |
+77,692
| New | +$1.05M |
|
122
Concentrix
CNXC
$3.28B
| $1.05M | 0.02% |
20,438
+11,654
| +133% | +$597K |
|
123
Hackett Group
HCKT
$560M
| $1.04M | 0.02% |
+39,550
| New | +$1.04M |
|
124
Photronics
PLAB
$1.31B
| $1.04M | 0.02% |
+41,813
| New | +$1.04M |
|
125
Veeva Systems
VEEV
$44.4B
| $1.02M | 0.02% |
4,854
+562
| +13% | +$118K |
|